Swerdlow et al
It does not whiten the skin, but it can make dull skin look more healthy and glowing
Endocrinology 2001 (N=animal cohort), lipolytic activity confirmed without GH-receptor activation Primary pharmacogenomic target / ADRB3 Trp64Arg (rs4994) polymorphism Secondary genomic targets / PPARG Pro12Ala, LIPE rs2267721, GHR exon-3 deletion Insulin axis effect / No clinically significant IGF-1 elevation in published animal data Regulatory status / Research/503A compounding
It's a revolutionary anti-aging treatment that revitalizes lackluster skin
Jungsuwadee P, Cole MP, Sultana R, Joshi G, Tangpong J, Butterfield DA, et al
AOD-9604 + CJC-1295 + Ipamorelin Researched Benefits: Facilitates analysis of GHRHR-mediated pulsatile growth hormone signaling and activation Supports investigation into ghrelin-mimetic modulation of somatotroph calcium-dependent exocytosis Enables research on C-terminal domain-specific lipolysis and fatty acid oxidation Useful for evaluating synergistic metabolic homeostasis and cellular bioenergetics assays Blend Specification: AOD-9604 6mg CJC-1295 3mg Ipamorelin 3mg Delivered today (order Mon-Fri before 12:00, delivery between 17:00 and 22:00) Including shipping costs, sent by blonwe.com Pick up at a blonwe.com collection point is possible 30 days to change your mind and free returns Day and night customer service Description The AOD-9604, CJC-1295, and Ipamorelin blend is formulated for comprehensive research into fat loss and muscle growth